Literature DB >> 22496256

CYP2C19 genotype and cardiovascular events.

Jessica L Mega, Eric J Topol, Marc S Sabatine.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2012        PMID： 22496256     DOI： 10.1001/jama.2012.444

Source DB:  PubMed          Journal:  JAMA        ISSN： 0098-7484            Impact factor:   56.272


× No keyword cloud information.
  7 in total

1.  A prospective randomized evaluation of a pharmacogenomic approach to antiplatelet therapy among patients with ST-elevation myocardial infarction: the RAPID STEMI study.

Authors:  D Y F So; G A Wells; R McPherson; M Labinaz; M R Le May; C Glover; A J Dick; M Froeschl; J-F Marquis; M H Gollob; L Tran; J Bernick; B Hibbert; J D Roberts
Journal:  Pharmacogenomics J       Date:  2015-04-07       Impact factor: 3.550

2.  Does cardiology hold pharmacogenetics to an inconsistent standard? A comparison of evidence among recommendations.

Authors:  Jasmine A Luzum; Jason C Cheung
Journal:  Pharmacogenomics       Date:  2018-09-10       Impact factor: 2.533

Review 3.  Pharmacogenomics of anti-platelet and anti-coagulation therapy.

Authors:  Adam S Fisch; Christina G Perry; Sarah H Stephens; Richard B Horenstein; Alan R Shuldiner
Journal:  Curr Cardiol Rep       Date:  2013-07       Impact factor: 2.931

Review 4.  Role of genetic testing in patients undergoing percutaneous coronary intervention.

Authors:  Jae Youn Moon; Francesco Franchi; Fabiana Rollini; Jose R Rivas Rios; Megha Kureti; Larisa H Cavallari; Dominick J Angiolillo
Journal:  Expert Rev Clin Pharmacol       Date:  2017-10-12       Impact factor: 5.045

Review 5.  Clopidogrel and warfarin pharmacogenetic tests: what is the evidence for use in clinical practice?

Authors:  Mohamed H A Shahin; Julie A Johnson
Journal:  Curr Opin Cardiol       Date:  2013-05       Impact factor: 2.161

Review 6.  Personalized antiplatelet and anticoagulation therapy: applications and significance of pharmacogenomics.

Authors:  Amber L Beitelshees; Deepak Voora; Joshua P Lewis
Journal:  Pharmgenomics Pers Med       Date:  2015-02-09

Review 7.  Pharmacogenomics of anti-platelet therapy: how much evidence is enough for clinical implementation?

Authors:  Christina G Perry; Alan R Shuldiner
Journal:  J Hum Genet       Date:  2013-05-23       Impact factor: 3.172
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.